IRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at began coverage on shares of IRIDEX (NASDAQ:IRIX – Free Report) in a report published on Monday morning. The firm issued a hold rating on the medical equipment provider’s stock. Separately, Stifel Nicolaus dropped their price target on IRIDEX from $3.00 to $2.00 in a research report on Friday, August 11th. Check Out Our Latest […]

Leave a Reply

Your email address will not be published.

Previous post Initiates Coverage on InVivo Therapeutics (NASDAQ:NVIV)
Next post IMAX (NYSE:IMAX) Lifted to “Buy” at